HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A. Financials Hapvida Participações e Investimentos S.A.
Equities
HAPV3
BRHAPVACNOR4
Managed Healthcare
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.06 BRL | +11.54% |
|
-2.17% | -8.76% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 46,944 | 56,690 | 40,394 | 36,150 | 33,353 | 30,502 | - | - |
| Enterprise Value (EV) 1 | 46,385 | 56,073 | 38,458 | 42,003 | 38,149 | 34,165 | 31,495 | 28,482 |
| P/E ratio | 54.8 x | 72.7 x | 79.8 x | -46.2 x | -44.5 x | 81.9 x | 26.9 x | 20.2 x |
| Yield | 0.46% | 0.36% | 0.08% | - | - | 0.2% | 1.26% | 2.25% |
| Capitalization / Revenue | 8.33 x | 6.63 x | 4.09 x | 1.52 x | 1.22 x | 1.05 x | 0.96 x | 0.88 x |
| EV / Revenue | 8.23 x | 6.55 x | 3.89 x | 1.77 x | 1.39 x | 1.18 x | 0.99 x | 0.82 x |
| EV / EBITDA | 43.8 x | 27.8 x | 25.7 x | 20 x | 13 x | 9.14 x | 6.79 x | 5.39 x |
| EV / FCF | 121 x | 58.4 x | -77.6 x | 178 x | 19.9 x | 17.7 x | 12.8 x | 9.46 x |
| FCF Yield | 0.83% | 1.71% | -1.29% | 0.56% | 5.03% | 5.64% | 7.84% | 10.6% |
| Price to Book | 6.54 x | 7.24 x | 3.8 x | 0.74 x | - | 0.62 x | 0.6 x | 0.56 x |
| Nbr of stocks (in thousands) | 3,673,263 | 3,714,927 | 3,891,570 | 7,116,195 | 7,495,107 | 7,494,248 | - | - |
| Reference price 2 | 12.78 | 15.26 | 10.38 | 5.080 | 4.450 | 4.070 | 4.070 | 4.070 |
| Announcement Date | 3/26/20 | 3/18/21 | 3/23/22 | 2/28/23 | 3/28/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,634 | 8,555 | 9,883 | 23,749 | 27,383 | 29,014 | 31,702 | 34,533 |
| EBITDA 1 | 1,059 | 2,020 | 1,495 | 2,100 | 2,932 | 3,739 | 4,636 | 5,283 |
| EBIT 1 | 981.7 | 1,267 | 543.3 | -155.9 | 681.2 | 1,669 | 2,754 | 3,565 |
| Operating Margin | 17.42% | 14.81% | 5.5% | -0.66% | 2.49% | 5.75% | 8.69% | 10.32% |
| Earnings before Tax (EBT) 1 | 1,152 | 1,133 | 492.9 | -1,448 | -673.7 | 591.2 | 1,712 | 2,608 |
| Net income 1 | 866.5 | 785.3 | 497.8 | -777.2 | -739.8 | 332.3 | 1,283 | 1,935 |
| Net margin | 15.38% | 9.18% | 5.04% | -3.27% | -2.7% | 1.15% | 4.05% | 5.6% |
| EPS 2 | 0.2332 | 0.2100 | 0.1300 | -0.1100 | -0.1000 | 0.0497 | 0.1515 | 0.2015 |
| Free Cash Flow 1 | 383 | 959.6 | -495.7 | 235.9 | 1,919 | 1,927 | 2,469 | 3,009 |
| FCF margin | 6.8% | 11.22% | -5.02% | 0.99% | 7.01% | 6.64% | 7.79% | 8.71% |
| FCF Conversion (EBITDA) | 36.16% | 47.52% | - | 11.23% | 65.43% | 51.54% | 53.26% | 56.96% |
| FCF Conversion (Net income) | 44.2% | 122.2% | - | - | - | 580.07% | 192.46% | 155.55% |
| Dividend per Share 2 | 0.0592 | 0.0542 | 0.008290 | - | - | 0.008000 | 0.0513 | 0.0916 |
| Announcement Date | 3/26/20 | 3/18/21 | 3/23/22 | 2/28/23 | 3/28/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,599 | 4,842 | 6,084 | 6,321 | 6,502 | 6,726 | 6,840 | 6,882 | 6,936 | 6,991 | 7,186 | 7,342 | 7,442 |
| EBITDA 1 | 388.4 | 414 | 582.3 | 505.3 | 598.7 | 634.5 | 606.2 | 742 | 949.7 | 1,012 | 856.8 | 946 | 1,085 |
| EBIT 1 | 155.5 | 191.1 | -131.7 | 109.2 | -100.6 | 93.3 | 64 | 102.9 | 420.9 | 407.7 | 323.1 | 414.4 | 540.2 |
| Operating Margin | 5.98% | 3.95% | -2.16% | 1.73% | -1.55% | 1.39% | 0.94% | 1.5% | 6.07% | 5.83% | 4.5% | 5.64% | 7.26% |
| Earnings before Tax (EBT) 1 | 133.7 | - | -391 | -236.3 | -616.3 | -336.7 | -183 | -268.5 | 114.5 | 151.4 | 65.67 | 156.4 | 284.4 |
| Net income | 200 | -182 | -312.3 | 35.15 | -316.7 | -341.6 | -161.1 | -205.7 | -30.65 | 83.51 | - | - | - |
| Net margin | 7.7% | -3.76% | -5.13% | 0.56% | -4.87% | -5.08% | -2.36% | -2.99% | -0.44% | 1.19% | - | - | - |
| EPS 2 | 0.0500 | -0.0300 | -0.0500 | 0.0100 | -0.0400 | -0.0500 | -0.0200 | -0.0300 | -0.0100 | 0.0100 | -0.005520 | 0.002030 | 0.0325 |
| Dividend per Share 2 | 0.008290 | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/23/22 | 5/16/22 | 8/11/22 | 11/9/22 | 2/28/23 | 5/16/23 | 8/9/23 | 11/9/23 | 3/28/24 | 5/13/24 | - | - | - |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 5,853 | 4,796 | 3,663 | 993 | - |
| Net Cash position 1 | 559 | 617 | 1,937 | - | - | - | - | 2,019 |
| Leverage (Debt/EBITDA) | - | - | - | 2.787 x | 1.635 x | 0.9797 x | 0.2142 x | - |
| Free Cash Flow 1 | 383 | 960 | -496 | 236 | 1,919 | 1,927 | 2,469 | 3,009 |
| ROE (net income / shareholders' equity) | 16% | 10.4% | 5.41% | -2.62% | -1.51% | 3.13% | 4.62% | 5.85% |
| ROA (Net income/ Total Assets) | - | - | - | 2.45% | -1% | 1.74% | 2.4% | 2.85% |
| Assets 1 | - | - | - | -31,698 | 74,185 | 19,062 | 53,409 | 67,858 |
| Book Value Per Share 2 | 1.950 | 2.110 | 2.740 | 6.860 | - | 6.570 | 6.810 | 7.240 |
| Cash Flow per Share | 0.1900 | 0.3600 | 0.0600 | 0.1400 | 0.3100 | - | - | - |
| Capex 1 | 274 | 366 | 708 | 736 | 412 | 440 | 995 | 938 |
| Capex / Sales | 4.86% | 4.28% | 7.16% | 3.1% | 1.5% | 1.52% | 3.14% | 2.72% |
| Announcement Date | 3/26/20 | 3/18/21 | 3/23/22 | 2/28/23 | 3/28/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
4.07
BRL
Average target price
5.9
BRL
Spread / Average Target
+44.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.76% | 5.83B | |
| -0.52% | 1.2B |
- Stock Market
- Equities
- HAPV3 Stock
- Financials Hapvida Participações e Investimentos S.A.
